Related Experiment Video
Updated: Nov 7, 2025
05:36
Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
Published on: January 26, 2024
1.6K
DNA-inspired nanomaterials for enhanced endosomal escape
Jinhyung Lee1, Ian Sands1, Wuxia Zhang1
1Department of Biomedical Engineering, University of Connecticut, Storrs, CT 06269.
Summary
Researchers developed novel Janus base nanopieces for effective RNA interference (RNAi) therapy delivery. These nanoparticles overcome endosomal entrapment, showing promise for future antiviral treatments like COVID-19.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- RNA interference (RNAi) therapeutics require efficient delivery of small interfering RNA (siRNA) into the cell cytoplasm.
- Endosomal entrapment of delivered siRNA is a significant challenge hindering RNAi therapeutic efficacy.
- Current delivery materials often exhibit limitations in endosomal escape and cytotoxicity.
Purpose of the Study:
- To develop novel delivery vehicles for RNAi therapeutics.
- To overcome the challenge of endosomal entrapment for enhanced siRNA delivery.
- To evaluate the potential of these new vehicles for antiviral applications.
Main Methods:
- Development of Janus base nanopieces (NPs) formed by bundles of Janus base nanotubes (JBNTs).
- Incorporation of RNA cargoes within NPs via charge interactions.
- Evaluation of cellular uptake via macropinocytosis and endosomal escape mechanisms.
- Assessment of cytotoxicity compared to conventional delivery materials like lipid nanoparticles and cationic polymers.
Main Results:
- Janus base nanopieces (NPs) efficiently entered cells via macropinocytosis.
- NPs demonstrated superior endosomal escape compared to lipid nanoparticles.
- NPs exhibited significantly lower cytotoxicity than traditional polymers and lipids due to their noncovalent, DNA-mimicking structure.
- Proof-of-concept experiments indicated NPs' potential for antiviral delivery.
Conclusions:
- Janus base nanopieces represent a promising new class of delivery vehicles for RNAi therapeutics.
- The unique properties of NPs, including efficient cellular entry and endosomal escape with low cytotoxicity, address key challenges in RNAi delivery.
- NPs show potential for future applications in antiviral therapies, including treatments for conditions like COVID-19.
